ChemicalBook > Product Catalog >API >Circulatory system drugs >Antiarrhythmics Drugs >TOCAINIDE

TOCAINIDE

TOCAINIDE Structure
CAS No.
41708-72-9
Chemical Name:
TOCAINIDE
Synonyms
W-36095;TOCAINIDE;Astra W-36095;TOCAINIDE USP/EP/BP;alanyl-2,6-xylidide;Naphthoic Acid Impurity 26;6'-propionoxylidide, 2-amino-2;2-amino-2',6'-propionoxylidide;N-(2-Aminopropionyl)-2,6-xylidine;N1-(2,6-dimethylphenyl)alaninamide
CBNumber:
CB8210193
Molecular Formula:
C11H16N2O
Molecular Weight:
192.26
MOL File:
41708-72-9.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:18

TOCAINIDE Properties

Melting point 246-266 °C
Boiling point 328.25°C (rough estimate)
Density 1.0529 (rough estimate)
refractive index 1.5750 (estimate)
storage temp. Keep in dark place,Inert atmosphere,Room temperature
form Solid
pka pKa 7.75(H2O t = 25.0±0.2 I = 0.01 (NaCl)) (Uncertain)
color White to off-white
CAS DataBase Reference 41708-72-9(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P264-P270-P301+P312-P330-P501
Hazard Codes  Xn
Risk Statements  22

TOCAINIDE Chemical Properties,Uses,Production

Uses

Tocainide is used for suppressing symptoms of ventricular arrhythmia and tachycardia, and for premature cardiac contractions.

Definition

ChEBI: A monocarboxylic acid amide in which 2,6-dimethylphenylaniline and isobutyric acid have combined to form the amide bond; used as a local anaesthetic.

World Health Organization (WHO)

Tocainide, an antidysrhythmic agent, was introduced in 1981 for the treatment of ventricular dysrhythmias. By 1984 its use was associated with cases of agranulocytosis, aplastic anaemia and thrombocytopenia, some of which were fatal. This led some regulatory authorities to restrict the indications for its use. The major manufacturer has subsequently restricted its use on a worldwide basis to the treatment of symptomatic ventricular dysrhythmias not responding to other therapy, or when other therapy is contraindicated.

Pharmacokinetics

The α-methyl group is believed to slow the rate of metabolism and, thereby, to contribute to oral activity. The plasma half-life of tocainide is approximately 12 hours, and nearly 50% of the drug may be excreted unchanged in the urine. Adverse effects associated with tocainide are like those observed with lidocaine—specifically, gastrointestinal disturbances and central nervous system effects.

Clinical Use

Tocainide (Tonocard) is an orally effective antiarrhythmic agent with close structural similarities to lidocaine. Tocainide is indicated for the treatment of symptomatic ventricular arrhythmias refractory to more conventional therapy. Serious noncardiac adverse effects limit its use to patients with life-threatening arrhythmias.

Side effects

Light-headedness, dizziness, or nausea occurs in approximately 15% of patients, paresthesias and numbness in 9%, and tremor in 8%.These adverse effects are generally mild in intensity, transient, and dose related. Overall, however, approximately 20% of patients prescribed tocainide discontinue therapy because of such effects. Serious immune-based side effects, such as pulmonary fibrosis, have been reported, and blood dyscrasias, such as agranulocytosis and thrombocytopenia, may occur in up to 0.2% of patients.

Drug interactions

When used with other class IB antiarrhythmic drugs, tocainide toxicity may be increased without significant gain in antiarrhythmic efficacy.

Precautions

Patients who are hypersensitive to tocainide or to local anesthetics of the amide type should not be exposed to tocainide.The presence of second- or third-degree heart block in the absence of an artificial pacemaker also contraindicates the use of tocainide.

TOCAINIDE Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 60)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 9030 58 Inquiry
Shanghai Acmec Biochemical Technology Co., Ltd. +undefined18621343501 China 33350 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57511 58 Inquiry
Shanghai Aladdin Biochemical Technology Co.,Ltd. +86-18521732826 China 48467 58 Inquiry
BEIJINGYIWANJINGRUI 15866847540 China 4084 58 Inquiry
Bide Pharmatech Ltd. 400-1647117 15221909166 China 63720 58 Inquiry
Nanjing Tengyi Biotechnology Co., Ltd 025-58851786 17714337195 China 5587 58 Inquiry
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd. 025-66061636 18013972705 China 6763 58 Inquiry

TOCAINIDE Spectrum

TOCAINIDE 2-amino-2',6'-propionoxylidide 2-amino-n-(2,6-dimethylphenyl)-propanamid 6'-propionoxylidide, 2-amino-2 alanyl-2,6-xylidide Astra W-36095 W-36095 2-Amino-N-(2,6-dimethylphenyl)propanamide N-(2-Aminopropionyl)-2,6-xylidine N1-(2,6-dimethylphenyl)alaninamide TOCAINIDE USP/EP/BP Sodium Channel,Na+ channels,Tocainide,tinnitus,lidocaine,Na channels,Inhibitor,inhibit Naphthoic Acid Impurity 26 41708-72-9 Cell Signaling and Neuroscience Sodium Channel Modulators Voltage-gated Ion Channels Other Sodium Channel Modulators Ion Channels Monovalent Ion Channels BioChemical Cell Biology Active Pharmaceutical Ingredients